Episodes

  • How Mesenchymal Stem Cells Are Shaping the Future of Medicine with Dr. Kilian Kelly

    How Mesenchymal Stem Cells Are Shaping the Future of Medicine with Dr. Kilian Kelly
    Jun 3 2025
    In this podcast episode, Dr. Kilian Kelly, CEO of Cynata Therapeutics, discusses the future of regenerative medicine! Discover how mesenchymal stem cells (MSCs)—powerful cells that repair and regenerate tissues—are revolutionizing treatments for a range of diseases. Dr. Kelly shares insights on Cynata’s groundbreaking Cymerus™ platform and the exciting potential of MSC therapies.
    Show more Show less
    29 mins
  • Patient Perspective with CAR-T Cell Therapy Advocate, Brad Watt

    Patient Perspective with CAR-T Cell Therapy Advocate, Brad Watt
    May 8 2025
    Our guest in this podcast episode is lymphoma survivor and CAR-T cell therapy patient advocate, Brad Watts. In this episode, Brad shares his personal story battling lymphoma at the young age of 29 along with his experience receiving an innovative cell therapy. This field is transforming lives and Brad is living proof of this potential.
    Show more Show less
    38 mins
  • How AI is Transforming Job Search and Recruiting in Life Sciences and Technology

    How AI is Transforming Job Search and Recruiting in Life Sciences and Technology
    Apr 24 2025
    AI is transforming job search, recruiting and hiring practices. Our guest in this podcast episode is Steve Swan, Practice Leader at The Swan Group. Steve is an Executive Recruiter specializing in technology for the Pharmaceutical and Biotech Industry. In this episode Steve shares his insights on how AI is transforming the hiring process.
    Show more Show less
    32 mins
  • From Nigeria to the USA: Gene Therapy Journey with Sickle Cell Warrior, Jimi Olaghere

    From Nigeria to the USA: Gene Therapy Journey with Sickle Cell Warrior, Jimi Olaghere
    Mar 24 2025
    Gene therapy offers significant hope for treating sickle cell disease (SCD), a genetic disorder caused by a single mutation in the hemoglobin gene. Recent advancements have led to promising developments and FDA approvals, but challenges remain. In this podcast episode, gene therapy survivor, Jimi Olaghere, shares his journey and offers hope to others with his inspirational message and through his advocacy for patients in the sickle cell community.
    Show more Show less
    37 mins
  • The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach

    The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach
    Mar 2 2025
    In this podcast episode, hear from Diakonos Oncology President and Chief Operating Officer Jay Hartenbach, who provides an update on the company's innovative dendritic cell vaccine therapy designed to tackle some of the most challenging cancers, including glioblastoma and pancreatic cancer
    Show more Show less
    25 mins
  • New Therapies for Brain Cancer with Neurosurgeon Thomas Chen, CEO of NeOnc

    New Therapies for Brain Cancer with Neurosurgeon Thomas Chen, CEO of NeOnc
    Jan 6 2025
    Dr. Thomas Chen is a world-renowned neurosurgeon, Director of Surgical Neuro-Oncology at the University of Southern California, and the founder and CEO of NeOnc Technologies. In this podcast episode we discuss the company’s unique approach to treating glioblastoma and other aggressive brain cancers.
    Show more Show less
    32 mins
  • From Meditation to Music: Exploring AI's Boundless Potential with Sreekanth Gopi

    From Meditation to Music: Exploring AI's Boundless Potential with Sreekanth Gopi
    Dec 18 2024
    Our guest in this podcast episode is Sreekanth Gopi, a leader in generative AI and machine learning. Sreekanth has applied AI to fields as diverse as physiological monitoring, meditation, and even generating multi-track Indian classical music. He’s published award-winning research on EEG spectral analysis and adaptive quiz generation using large language models, participated in over 12 AI hackathons—winning two—and is now a Prompt Engineer at Morgan Stanley, where he fine-tunes cutting-edge LLM interactions for real-world applications. In this episode we explore how AI is redefining stress management and revolutionizing real-time physiological data applications. Tune in to learn about the world of generative artificial intelligence— and looking at its transformative potential in mental health and stress management.
    Show more Show less
    32 mins
  • How Arvinas is Transforming Cancer and Neuroscience Therapies: An Interview with CBO, Randy Teel, PhD

    How Arvinas is Transforming Cancer and Neuroscience Therapies: An Interview with CBO, Randy Teel, PhD
    Dec 3 2024
    Arvinas is a biotech company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. In this podcast episode, Dr. Randy Teel discusses the company's PROTAC protein degrader technology platform and its pipeline of clinical-stage assets, with a focus on vepdegestrant, the company's lead asset that is being co-developed together with partner Pfizer, for the treatment of women with early and locally advanced or metastatic ER+/HER2- breast cancer.
    Show more Show less
    36 mins
adbl_web_global_use_to_activate_webcro805_stickypopup